original ) (raw )Head- to head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard
Einat Even-sapir
Journal of Nuclear Medicine, 2019
View PDFchevron_right
Cold Kit PSMA PET Imaging: Phase I study of (68)Ga-THP-PSMA PET/CT in patients with prostate cancer
Rodney Hicks
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017
View PDFchevron_right
Re: The role of 68Ga-PSMA-PET/CT in radiotherapy planning in prostate cancer
Yasemin Cihan
International braz j urol
View PDFchevron_right
Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT
isa guney
Egyptian Journal of Radiology and Nuclear Medicine
View PDFchevron_right
Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
T. Ebenhan , Janine Suthiram , Biljana Marjanovic-Painter , Moshe Modiselle , Mariza Vorster
Molecules
View PDFchevron_right
Evaluation of hybrid PET/CT imaging with the 68Ga-labelled PSMA ligand in patients with prostate cancer and biochemical progression in the low-range values of PSA after radical prostatectomy
Klara Dokova
Scripta Scientifica Medica, 2022
View PDFchevron_right
Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer
Sarah Piron
Journal of Nuclear Medicine
View PDFchevron_right
Standardization of the [68Ga]Ga-PSMA-11 Radiolabeling Protocol in an Automatic Synthesis Module: Assessments for PET Imaging of Prostate Cancer
Luciana Malavolta
Pharmaceuticals, 2021
View PDFchevron_right
Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients
Jan Axelsson
2019
View PDFchevron_right
{"__content__"=>"Intra-individual comparison ofF-PSMA-1007 andF-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: A pilot study.", "sup"=>[{"__content__"=>"18"}, {"__content__"=>"18"}]}
Mariza Vorster
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017
View PDFchevron_right
68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
Antonia Dimitrakopoulou-Strauss
Clinical Nuclear Medicine, 2016
View PDFchevron_right
Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617
Roger Schibli
Scientific Reports, 2019
View PDFchevron_right
Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
Reza Vali
Journal of Clinical Medicine, 2020
View PDFchevron_right
Clinical utility of gallium-68 PSMA PET/CT scan for prostate cancer
shivakumar swamy
Indian Journal of Nuclear Medicine, 2017
View PDFchevron_right
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
Ulrike Bauder-wüst
Pharmaceuticals (Basel, Switzerland), 2014
View PDFchevron_right
Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
Nat Lenzo
Diagnostics
View PDFchevron_right
Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer
Mouza Al-sharhan
2020
View PDFchevron_right
Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis
Dieter Fedders
EJNMMI research, 2021
View PDFchevron_right
The impact of (68)Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study
Andrew Kneebone
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017
View PDFchevron_right
Article Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
Moshe Modiselle
2015
View PDFchevron_right
Diagnostic Challenges in Prostate Cancer and 68Ga-PSMA PET Imaging: A Game Changer?
Maseeh uz Zaman
Asian Pacific journal of cancer prevention : APJCP, 2017
View PDFchevron_right
Psma for Pet Imaging of Prostate Cancer
Suphansa Kijprayoon
The Bangkok Medical Journal
View PDFchevron_right
68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients
Yasemin Sanli
Nuclear Medicine Communications, 2018
View PDFchevron_right
64Cu-PSMA-617 PET/CT Imaging of Prostate Adenocarcinoma: First In-Human Studies
yasaman ahmadi
Cancer Biotherapy and Radiopharmaceuticals, 2016
View PDFchevron_right
[68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer
Nader Hirmas
View PDFchevron_right
Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients
Meltem Caglar
Clinical Nuclear Medicine, 2019
View PDFchevron_right
64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window
Brigitte Guérin
Pharmaceuticals
View PDFchevron_right
Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain
Elia Del Cerro
Reports of Practical Oncology & Radiotherapy, 2020
View PDFchevron_right
Prospective Comparison of the detection rate of18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy
Quoc Nguyen
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015
View PDFchevron_right